Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Fresan-Restituto D, Lacalle-Fabo E, Martin-Bujanda M, Sarobe-Carricas MT, et al. Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one. Rev Neurol 2023;76:213-216.
PMID: 36908035


Privacy Policy